Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
Pregnancy and breastfeeding insufficient data
The fat loss process continues to improve as the peptide takes effect
CYANOCOBALAMIN- cyanocobalamin injection, USP
US$ 26.87
US$ 28.23
US$ 25.68
US$ 29.31
US$ 25.41
US$ 29.16
US$ 23.75
US$ 23.56
US$ 25.07
US$ 23.34
US$ 25.34
US$ 20.54
